###begin article-title 0
###xml 79 94 <span type="species:ncbi:10090">transgenic mice</span>
Overexpression of a mutant form of TGFBI/BIGH3 induces retinal degeneration in transgenic mice
###end article-title 0
###begin p 1
The first two authors contributed equally to this work.
###end p 1
###begin p 2
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 2
###begin title 3
Purpose
###end title 3
###begin p 4
###xml 154 165 154 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI/BIGH3</italic>
###xml 286 297 286 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI/BIGH3</italic>
###xml 139 144 <span type="species:ncbi:9606">human</span>
###xml 344 359 <span type="species:ncbi:10090">transgenic mice</span>
Despite ubiquitous expression of the keratoepithelin (KE) protein encoded by the transforming growth factor beta induced/beta induced gene human clone 3 (TGFBI/BIGH3) gene, corneal dystrophies are restricted to the cornea, and no other tissues are affected. We investigated the role of TGFBI/BIGH3 in Groenouw corneal dystrophies by generating transgenic mice overexpressing TGFBI/BIGH3 containing the R555W mutation.
###end p 4
###begin title 5
Methods
###end title 5
###begin p 6
###xml 61 72 61 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI/BIGH3</italic>
###xml 225 228 225 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PGK</italic>
###xml 55 60 <span type="species:ncbi:9606">human</span>
###xml 380 384 <span type="species:ncbi:10090">mice</span>
Transgenic animals expressing the Groenouw mutation of human TGFBI/BIGH3 were generated using lentiviral vectors. The line expressed TGFBI/BIGH3 containing the R555W mutation under the control of the phosphoglycerate kinase (PGK) promoter. Expression of the transgene was monitored by Southern and western blotting and by RT-PCR. Electroretinogram analysis was performed and four mice were subjected to complete necroscopy.
###end p 6
###begin title 7
Results
###end title 7
###begin p 8
Transgene expression was observed in different organs although without specific expression in the cornea. The overall morphology of the transgenic animals was not severely affected by KE overexpression. However, we observed an age-dependent retinal degeneration both functionally and histologically. Female-specific follicular hyperplasia in the spleen and increased levels of lipofuscin in the adrenal gland were also seen in transgenic animals.
###end p 8
###begin title 9
Conclusions
###end title 9
###begin p 10
Cellular degeneration in the retina of transgenic animals suggest that perturbation of the transforming growth factor beta (TGFbeta) family regulation may affect photoreceptor survival and may induce possible accelerated aging in several tissues. No corneal phenotype could be observed, probably due to the lack of transgene expression in this tissue.
###end p 10
###begin title 11
Introduction
###end title 11
###begin p 12
###xml 403 404 403 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 502 513 502 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI/BIGH3</italic>
###xml 550 551 550 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 751 752 751 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 753 754 753 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human corneal dystrophies (HCD) are rare hereditary diseases characterized by bilateral loss of corneal transparency due to the slow accumulation of amyloid as well as non-amyloid deposits. Symptoms may become present as early as birth, but more frequently they develop during adolescence and gradually progress throughout life. We and others have mapped four different forms of HCD to chromosome 5q31 [1] and subsequently recognized that mutations in the transforming growth factor beta-induced gene (TGFBI/BIGH3) were the causes of these diseases [2]. Although mutations at two specific amino acids (R124 and R555) are responsible for the great majority of the cases, isolated families have been described with mutations in other parts of the gene [3,4].
###end p 12
###begin p 13
###xml 11 22 11 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI/BIGH3</italic>
###xml 105 116 105 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI/BIGH3</italic>
###xml 231 232 231 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 329 340 329 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI/BIGH3</italic>
###xml 590 601 590 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI/BIGH3</italic>
###xml 276 281 <span type="species:ncbi:10090">mouse</span>
###xml 323 328 <span type="species:ncbi:9606">human</span>
###xml 988 992 <span type="species:ncbi:10090">mice</span>
Studies of TGFBI/BIGH3-related HCD are of great interest, and while keratoepithelin (KE), the product of TGFBI/BIGH3, is ubiquitously expressed except in the brain, it is still not understood why KE deposits only occur in corneas [5]. In this report, we describe a transgenic mouse line expressing an R555W mutated form of human TGFBI/BIGH3 in an attempt to generate a model for the Groenouw type I HCD. Extensive postmortem analyses included macroscopic and histopathologic analyses of organs and measures of the principal metabolic enzymes. Our data indicate that transgene expression of TGFBI/BIGH3 induced an age-dependent retinal degeneration, associated with concomitant significantly attenuated cone and rod responses. Female animals also displayed a mild follicular hyperplasia in the spleen and lipofuscin expression in the adrenal glands, suggesting an accelerated aging process. No other histopathologic abnormalities were noticed in the transgenic animals compared to control mice. In particular, no transgenic RNA expression was observed in the corneas of these animals.
###end p 13
###begin title 14
Material and methods
###end title 14
###begin title 15
Lentivirus generation
###end title 15
###begin p 16
###xml 178 179 178 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 46 72 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
###xml 527 533 <span type="species:ncbi:9913">bovine</span>
###xml 751 756 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Recombinant lentiviral particles containing a vesicular stomatitis virus G protein (VSV-G) envelop were produced by transient transfection of 293T cells as previously described [6]. Briefly, 293T cells were transfected with the different plasmids using calcium phosphate, the medium harvested 36 h later and centrifuged at 70,000x g. Viral supernatants were concentrated by a second ultracentrifugation at 70,000x g for 90 min at 4 degreesC. The viral pellets were resuspended in a minimal of volume of PBS containing 10 mg/ml bovine serum albumin (BSA). Aliquots of 5 microl were then stored at -70 degreesC until further use. Total particle concentration of the viral stocks was estimated by quantification of the p24 capsid protein using Retro-TEK HIV-1 p24 Antigen ELISA kit (ZeptoMetrixCorporation, Buffalo, New York).
###end p 16
###begin p 17
###xml 325 326 325 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 327 328 327 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 538 539 538 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 680 682 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 89 94 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 163 166 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 205 208 <span type="species:ncbi:10116">rat</span>
###xml 221 226 <span type="species:ncbi:9606">human</span>
###xml 379 384 <span type="species:ncbi:10090">mouse</span>
###xml 398 401 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 405 435 <span type="species:ncbi:11665">equine infectious anemia virus</span>
###xml 437 441 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 526 529 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 559 563 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 612 617 <span type="species:ncbi:9606">human</span>
###xml 644 647 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
High transduction efficiency was observed in corneal endothelial cells in vivo, using an HIV-1-derived lentivirus with a cytomegalovirus immediate early promoter (CMV). A similar efficacy was reported for rat, ovine, and human cornea explants infected in vitro with a lentiviral vector carrying a simian virus (SV) promoter [7,8]. Previous results have shown similar efficacy in mouse cornea using HIV or equine infectious anemia virus (EIAV) vectors containing the vectors containing the VSV-G envelop (VSVG) envelop and the CMV vector [9]. In cell culture, EIAV has also shown a strong efficiency to transduce human endothelial cells using a CMV promoter and the VSV-G envelop [10].
###end p 17
###begin p 18
###xml 8 19 8 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI/BIGH3</italic>
###xml 216 219 216 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PGK</italic>
###xml 221 229 221 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 236 239 236 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PGK</italic>
###xml 342 344 342 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 345 347 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 390 393 390 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PGK</italic>
###xml 548 550 548 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 2 7 <span type="species:ncbi:9606">human</span>
###xml 176 181 <span type="species:ncbi:10090">mouse</span>
###xml 384 389 <span type="species:ncbi:10090">mouse</span>
A human TGFBI/BIGH3 cDNA with the R555W Groenouw mutation was ligated into BamHI sites of a replication-deficient, self-inactivating plasmid (pSIN) under the regulation of the mouse phosphoglycerate kinase promoter (PGK; Figure 1). The PGK promoter is a ubiquitous promoter that was successfully used with lentiviral vectors in many tissues [11,12]. Since the GC-rich sequence of the mouse PGK promoter contains only three ATG triplets, this promoter is particularly suitable for lentiviral constructions as compared to other ubiquitous promoters [13]. Presence or absence of mutation was confirmed by direct sequencing of the insert.
###end p 18
###begin p 19
###xml 119 144 <span type="species:ncbi:35269">woodchuck hepatitis virus</span>
Lentiviral backbone containing the phosphoglycerate kinase promoter and the post-transcriptional regulatory element of woodchuck hepatitis virus. Note the Groenouw (R555W) mutation, the localization of the probe used for Southern blotting, and the unique BamHI site (black arrow). In the figure, n indicates the number of founders obtained for the construct.
###end p 19
###begin title 20
Lentiviral vector preparation
###end title 20
###begin p 21
###xml 201 212 201 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI/BIGH3</italic>
###xml 525 527 525 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 195 200 <span type="species:ncbi:9606">human</span>
###xml 327 336 <span type="species:ncbi:9995">woodchuck</span>
A replication-deficient, self-inactivating (SIN) backbone was obtained from Patrick Aebischer (Ecole Polytechnique Federale de Lausanne [EPFL], Lausanne, Switzerland). The transgene encoding the human TGFBI/BIGH3 cDNA was inserted into a backbone containing the SIN followed by the elongation factor-1 minimum promoter and the woodchuck hepatitis post-transcriptional regulatory elements (SIN-W-EFs) to generate the lentiviral vector LV_BIGH3. The lentiviral vector was produced as described above and previously by Naldini [14].
###end p 21
###begin title 22
Generation of transgenic animals
###end title 22
###begin p 23
###xml 27 31 <span type="species:ncbi:10090">mice</span>
###xml 291 295 <span type="species:ncbi:10090">Mice</span>
All procedures implicating mice manipulation were performed in agreement with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and were approved by the local Veterinary Committee Office on Use and Care of Animals in Research of Canton Vaud, Lausanne, Switzerland. Mice (120 total, 60 males and 60 females) were maintained on a 14:10 light-dark cycle under standard housing conditions. Water and standard high protein food (Kliba, Switzerland) were available at libitum.
###end p 23
###begin p 24
###xml 60 62 60 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 639 640 633 634 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 255 260 <span type="species:ncbi:9606">human</span>
Transgenesis was performed according to standard protocols [15]. Briefly, four-week-old National Marine Research Institute (NMRI) females were superovulated by intraperitoneal injection of 5U pregnant mare's serum gonadotropin followed by injection of 5U human chorionic gonadotropin 48 h later. Superovulated females were mated with NMRI males, and embryos were collected at zygote stage on the following day. Zygotes were then immediately microinjected into the perivitelline space with 10-100 picoliters of about 109 transduction unit/ml lentiviral preparation and incubated in M16 medium (Sigma, St. Louis, MO) at 37 degreesC and 5% CO2 atmosphere. On the following day, two-cell stage embryos were selected and transferred into the oviduct of 3 pseudopregnant NMRI females.
###end p 24
###begin p 25
###xml 5 9 <span type="species:ncbi:10090">mice</span>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
###xml 203 208 <span type="species:ncbi:10090">mouse</span>
###xml 304 308 <span type="species:ncbi:10090">mice</span>
###xml 348 352 <span type="species:ncbi:10090">mice</span>
NMRI mice are widely used as experimental models in many fields of general biology. Albino NMRI mice are widely used in transgenesis since embryos derived from this strain are more resistant than inbred mouse embryos such as C57/BL6 and their use results in a higher transgenesis rate. Moreover, outbred mice embryos are more resistant than inbred mice embryos and lead to a higher transgenesis rate.
###end p 25
###begin title 26
RNA extraction
###end title 26
###begin p 27
###xml 72 76 <span type="species:ncbi:10090">mice</span>
Several organs including retina and cornea were removed from euthanized mice and directly placed in ice. Euthanasia was performed by neck dislocation. Total RNA was extracted using Trizol(R) reagent according to the manufacturer's instructions (Invitrogen, Carlsbad, CA). RNA concentration and purity were measured using RiboGreen(R) (Molecular Probes, Eugene, OR) according to the manufacturer's instructions.
###end p 27
###begin title 28
cDNA synthesis
###end title 28
###begin p 29
Equal amounts (1 microg) of RNA were used to synthesize cDNA using StrataScript Reverse Transcriptase according to the manufacturer's instructions (Stratagene, La Jolla, CA).
###end p 29
###begin title 30
Genomic DNA extraction
###end title 30
###begin p 31
###xml 30 35 <span type="species:ncbi:10090">mouse</span>
Genomic DNA was obtained from mouse tail biopsies as follows: cut tail was transferred into lysis buffer, which contained 100 mM TrisHCl, pH 8.5, 5 mM EDTA, 0.2% sodium dodecyl sulfate (SDS), 200 mM NaCl, and 100 microg proteinase K/ml, and incubated in a rotating shaker at 56 degreesC overnight. After complete lysis, samples were centrifuged for 2 min and the supernatant was transferred into isopropanol. After a second 2 min centrifugation, supernatant was removed and the pellet was dissolved in 150 microl 10 mM TrisHCl and 0.1 mM EDTA, pH 7.5, and incubated at 80 degreesC for 4 min. The obtained genomic DNA was directly used to perform PCRs.
###end p 31
###begin title 32
Transgene integration, expression, and monitoring
###end title 32
###begin p 33
###xml 75 86 75 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI/BIGH3</italic>
###xml 508 515 474 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 871 878 837 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 528 533 <span type="species:ncbi:9606">human</span>
###xml 1263 1268 <span type="species:ncbi:10090">mouse</span>
###xml 1358 1363 <span type="species:ncbi:9606">human</span>
Transgene integration was determined from biopsies by PCR amplification of TGFBI/BIGH3. Genomic DNA (500 ng or 1 microg), obtained as described in the previous section, was amplified. If not otherwise stated, the conditions were as follows: a first incubation of 5 min at 94 degreesC, then 35 cycles of 1 min at 94 degreesC, 1 min at 56 degreesC and 3 min at 72 degreesC, and finally a last extension of 10 min at 72 degreesC. The following primers were used: Big-Big_F, Big-Big_R, PGK-BIG_F, and PGK-BIG_R (Table 1). Since the human transgene sequence contained a unique BamH1 site in a specific PCR-amplified region, transgene transcription was monitored by digestion of the PCR amplified cDNA produced by reverse-transcribed RNA. PCR was performed from 100 to 500 ng cDNA amplified by Hotstart Taq polymerase (Qiagen, Hilden, Germany), with the primers 227F and 649R (Table 1) and the following conditions: a first incubation of 5 min at 95 degreesC, then 30 cycles of 1 min at 95 degreesC, 1 min at 55 degreesC and 1 min at 72 degreesC, with a final extension of 10 min at 72 degreesC. BamHI digestion was performed from 0.1 to 1 microg gel purified PCR product incubated 8-16 h at 37 degreesC with 1 unit of enzyme in Roche B buffer. Digestion of endogenous mouse TGFBI/BIGH3 resulted in a product of about 500 bp whereas BamHI digestion of transgenic (human) TGFBI/BIGH3 resulted in two bands of about 300 bp and 200 bp.
###end p 33
###begin title 34
###xml 63 68 <span type="species:ncbi:10090">mouse</span>
List of all the primers used in the generation of a transgenic mouse line.
###end title 34
###begin p 35
###xml 90 95 <span type="species:ncbi:10090">mouse</span>
This table indicates the primers used in the different steps of generating the transgenic mouse line. All the primers are indicated in a 5'-3' direction and in triplet sets.
###end p 35
###begin p 36
###xml 335 346 329 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI/BIGH3</italic>
###xml 503 511 497 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 635 637 629 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 734 741 728 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 1201 1208 1195 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 1256 1263 1250 1257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 1413 1418 <span type="species:ncbi:10090">mouse</span>
The number of transgene integration sites was monitored by Southern blot. Genomic DNA obtained was digested with EcoRI overnight at 37 degreesC. The digested DNA was precipitated with 3M sodium acetate (pH 5.2)/EtOH on ice and resuspended in trishydroxymethylaminomethane - ethylene diamine tetraacetic acid (TE) buffer. A full-length TGFBI/BIGH3 cDNA was radiolabeled with the random primed technique and hybridized to the membrane. Hybridization was performed with a probe from the vector's backbone (Figure 1). Integration sites were also monitored by linear amplification mediated polymerase chain reaction (LAM-PCR) as described [16]. Briefly, a linear PCR with a long-terminal repeat (LTR)-specific biotinylated primer (LTR1 in Table 1) was performed. The specific amplified PCR products were sorted by magnetic tag selection of extension primers. A second DNA strand of each target sequence was synthesized by random hexanucleotide priming. Double-stranded DNA was digested with CfoI, and an asymmetric ligation cassette was ligated to the end of CfoI-digested fragments. Nested exponential PCR amplifications were then performed with linker cassette (LC)-specific forward primers (LC primers, Table 1) and LTR-specific reverse primers (LTR primers Table 1). Primer pairs were LC1-LTR2, LC2-LTR3, and LC3-LTR4. Finally, LAM-PCR products were subcloned in pGEM-T easy vector, sequenced, and blasted against mouse genomic DNA.
###end p 36
###begin title 37
Protein extraction
###end title 37
###begin p 38
###xml 46 51 <span type="species:ncbi:10090">mouse</span>
Retina and cornea were removed from dissected mouse eyes. Proteins were extracted and homogenized for 10 min in 100 microl ice-cold RIPA buffer, which consisted of 50 mM Tris-Cl pH 8.0, 150 mM NaCl, 1% NP-40, 0.5% deoxycholate, and 0.1% SDS, and also contained protease (Roche, Mannheim, Germany) and 1% phosphatase (Sigma) inhibitor cocktails. Further homogenization through a needle was performed when necessary. Retinas or corneas were homogenized in ice-cold RIPA buffer with an 18 gauge needle. Protein concentrations were measured by bisinchoninic acid (BCA) protein assay (Pierce, Rockford, IL).
###end p 38
###begin title 39
Western blot analysis
###end title 39
###begin p 40
###xml 457 459 457 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 410 416 <span type="species:ncbi:9986">rabbit</span>
###xml 435 440 <span type="species:ncbi:9606">human</span>
###xml 515 526 <span type="species:ncbi:3704">horseradish</span>
###xml 546 550 <span type="species:ncbi:9925">goat</span>
Equal amounts of protein samples were separated by 8% SDS-PAGE gel and transferred to a polyvinylidene difluoride membrane (Westran clear signal; Whatman Inc., Maidstone, UK). Membranes were then blocked for 1 h at room temperature with Tris-buffered saline, composed of 150 mM NaCl and 50 mM Tris, pH 7.5, and contained 0.1% Tween (TBS-T) and 5% nonfat dry milk. Next, membranes were probed with a polyclonal rabbit antiserum against human KE-2 (1/4,000) [17] for 2 h in TBS-T with 5% nonfat dry milk. A secondary horseradish peroxydase-coupled goat antirabbit IgG (1/25,000; Amersham Biosciences, Buckinghamshire, UK) was used for 1 h at room temperature in TBS-T with 5% nonfat dry milk. After three washes in TBS-T, the antigen-antibody complexes were detected by chemiluminescence using the Enhanced Chemi Luminescence Plus (ECL+) western blotting system (Amersham Biosciences). Results were quantified under conditions of linearity by integration of the density of total area of each band using a video densitometer and LabWorks 4.0 software (Media Cybernetics, Bethesda, MD). Results are expressed as a percentage of the control optical density.
###end p 40
###begin title 41
###xml 39 44 <span type="species:ncbi:10090">mouse</span>
Hematoxylin-eosin and DAPI staining of mouse eyes
###end title 41
###begin p 42
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse eyes (8 transgenic and 3 wild type) were dissected and fixed in 4% paraformaldehyde for 1 h. Fixed eyes were then embedded in 30% albumin egg, 3% gelatin (Yazzula buffer) and frozen in liquid nitrogen to be sectioned at 14 microm with a cryostat. Slides were rehydrated and stained with hematoxylin for 10 min. After two washes, slides were stained with eosin for 1 min and fixed in 50% glycerol-50% PBS.
###end p 42
###begin p 43
###xml 287 288 287 288 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</sup>
Different slides were stained for 15 min with DAPI safe from the light and then fixed with FluorSave. In order to analyze similar fields, we evaluated slides on which the optical nerve was visible on a BX51 Olympus microscope at 100X or 400X magnification. Pictures were taken using CellD imaging software (Carl Zeiss, Jena, Germany).
###end p 43
###begin title 44
Autopsy
###end title 44
###begin p 45
###xml 16 31 <span type="species:ncbi:10090">transgenic mice</span>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
Eight-month-old transgenic mice (two males and two females) and wild-type (one male and one female) living mice were sent to Frimorfo Inc. (Fribourg, Switzerland) for an in depth analysis of all organs. This analysis includes macroscopic inspection, necroscopy and histopathological evaluation completed by full X-ray analysis and blood analysis (blood chemistry and hematology).
###end p 45
###begin title 46
Results
###end title 46
###begin title 47
Generation and validation of the transgenic model
###end title 47
###begin p 48
###xml 280 281 278 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 481 489 479 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
###xml 560 571 558 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI/BIGH3</italic>
###xml 644 655 642 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI/BIGH3</italic>
###xml 363 367 <span type="species:ncbi:10090">mice</span>
###xml 554 559 <span type="species:ncbi:10090">mouse</span>
###xml 637 642 <span type="species:ncbi:9606">human</span>
In total, 25 independent PGK-Groenouw transgenic founders were generated, with a transgene integration averaged ratio of 37%+/-18 of the newborns, depending on the lentiviral batch and titer. In this study, we observed that only batches of lentiviral particles titrated above 1x108 TU/ml were effective in generating transgenic animals. We routinely screened the mice by PCR for transgene integration, using primers specific for the transgene and RT-PCR for transcript expression (Figure 2). As described in the previous section, digestion of endogenous mouse TGFBI/BIGH3 resulted in only one band whereas BamHI digestion of transgenic (human) TGFBI/BIGH3 resulted in two bands.
###end p 48
###begin p 49
###xml 25 36 25 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI/BIGH3</italic>
###xml 54 56 54 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A:</bold>
###xml 114 125 114 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI/BIGH3</italic>
###xml 239 241 239 241 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B:</bold>
###xml 409 410 409 410 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 97 102 <span type="species:ncbi:9606">human</span>
###xml 107 113 <span type="species:ncbi:10090">murine</span>
###xml 227 232 <span type="species:ncbi:9606">human</span>
###xml 379 394 <span type="species:ncbi:10090">transgenic mice</span>
Screening for transgenic TGFBI/BIGH3 mRNA expression. A: The scheme shows the difference between human and murine TGFBI/BIGH3. Note the localization of the primers used for the PCR and the unique BamHI site present only in the human gene. B: Migration of undigested corneal (lanes 2 and 4) or BamHI digested retinal (lanes 1 and 3) cDNA amplimers from two different PGK-Groenouw transgenic mice, as showed in A. L indicates the 1-kb DNA ladder lane.
###end p 49
###begin p 50
###xml 161 170 161 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3A</xref>
###xml 692 699 692 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 101 116 <span type="species:ncbi:10090">transgenic mice</span>
###xml 333 348 <span type="species:ncbi:10090">transgenic mice</span>
Southern blot analyses were used to evaluate the number of integration sites in the F1 generation of transgenic mice. Generally one to four sites were observed (Figure 3A). Based on the size of the fragments, and assuming no recombination in the region of the probe, five integration sites were seen in the Southern blot analysis of transgenic mice. It is assumed that, with successive generations, the number of integration sites will diminish. Moreover, localization of integration sites were monitored in some transgenic animals using linear amplification mediated polymerase chain reaction (LAM-PCR) method. Integration of lentiviral vectors were seen in chromosomes 7, 8, 14, 19, and Y. Table 2 indicates the exact positions of the identified integration sites.
###end p 50
###begin p 51
###xml 0 11 0 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI/BIGH3</italic>
###xml 63 65 63 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A:</bold>
###xml 216 218 216 218 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B:</bold>
###xml 461 462 461 462 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 399 404 <span type="species:ncbi:10090">mouse</span>
TGFBI/BIGH3 expression analyzed by Southern and western blots. A: The Southern blot shows various integration sites of the transgene in 27 PGK-Groenouw F1 transgenic animals originating from four different founders. B: The Western blot against TGFBI/BIGH3 of the wild type (left panel) shows no expression in the retina and the brain in comparison with the western blot of a PGK-Groenouw transgenic mouse (right panel). The following abbreviations are used in (B): cornea (C ), retina (R ), brain (B), heart (H), liver (L), spleen (S), kidney (K), and muscle (M). The arrow indicates 64 kDa band corresponding to keratoepithelin.
###end p 51
###begin title 52
###xml 39 54 <span type="species:ncbi:10090">transgenic mice</span>
Location of virus integration sites in transgenic mice
###end title 52
###begin p 53
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 19 24 <span type="species:ncbi:10090">Mouse</span>
17 different mice (Mouse ID) have been submitted to linear amplification mediated polymerase chain reaction (LAM-PCR). Five different integration sites have been identified, and each of them is characterized by its chromosome, its contig and its exact position.
###end p 53
###begin p 54
###xml 216 219 216 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PGK</italic>
###xml 328 337 328 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3B</xref>
###xml 478 487 478 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3B</xref>
###xml 565 574 565 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3B</xref>
###xml 145 160 <span type="species:ncbi:10090">transgenic mice</span>
###xml 284 299 <span type="species:ncbi:10090">transgenic mice</span>
###xml 322 326 <span type="species:ncbi:10090">mice</span>
###xml 410 425 <span type="species:ncbi:10090">transgenic mice</span>
###xml 472 476 <span type="species:ncbi:10090">mice</span>
We additionally monitored tissue expression in glycerol-embedded sectioned tissues (not shown) and by western blot using an anti-KE2 antibody in transgenic mice expressing the R555W mutation under the control of the PGK promoter. KE expression was slightly increased in the retina of transgenic mice compared to wild-type mice (Figure 3B, left panel). We also observed a clear expression of KE in the brain of transgenic mice, whereas no expression was found in wild-type mice (Figure 3B). Overall, it did not seem to affect endogenous expression in other tissues (Figure 3B, left and right panels). The figure also showed smaller bands corresponding to degradation products of the protein.
###end p 54
###begin title 55
###xml 93 97 <span type="species:ncbi:10090">mice</span>
Organ comparisons between phosphoglycerate kinase promoter-Groenouw transgenic and wild-type mice
###end title 55
###begin p 56
###xml 44 59 <span type="species:ncbi:10090">transgenic mice</span>
###xml 133 137 <span type="species:ncbi:10090">mice</span>
###xml 139 154 <span type="species:ncbi:10090">Transgenic mice</span>
The weight of the organs of eight-month-old transgenic mice (two males and two females) was compared to age- and sex-matched control mice. Transgenic mice appeared to be healthy and did not display particular abnormal behavioral signs for up to 18 months.
###end p 56
###begin p 57
###xml 156 163 156 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 220 228 220 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4</xref>
###xml 321 328 321 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 401 408 401 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 0 15 <span type="species:ncbi:10090">Transgenic mice</span>
###xml 150 154 <span type="species:ncbi:10090">mice</span>
###xml 184 188 <span type="species:ncbi:10090">mice</span>
Transgenic mice tended to have increased organ size and weight, except for the thymus that was reduced in size compared to age-matched wild-type NMRI mice (Table 3). Transgenic female mice showed follicular hyperplasia (Figure 4, lower panel), increased amount of extramedullary hematopoiesis, and higher spleen weights (Table 3). The weight of the heart and kidneys was higher in transgenic females (Table 3), but morphology was normal.
###end p 57
###begin title 58
###xml 46 50 <span type="species:ncbi:10090">mice</span>
Mean organ weight of transgenic and wild-type mice.
###end title 58
###begin p 59
###xml 34 38 <span type="species:ncbi:10090">mice</span>
Four transgenic and two wild-type mice were sacrificed and weighed. SEM indicates the standard deviation observed for each organs, and asterisk indicate significant differences between transgenic and wild-type organ (the asterisk denotes a p<0.05).
###end p 59
###begin p 60
###xml 189 190 189 190 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 233 234 233 234 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 311 312 311 312 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 61 66 <span type="species:ncbi:10090">mouse</span>
###xml 91 96 <span type="species:ncbi:10090">mouse</span>
###xml 192 197 <span type="species:ncbi:10090">mouse</span>
###xml 236 241 <span type="species:ncbi:10090">mouse</span>
###xml 279 294 <span type="species:ncbi:10090">transgenic mice</span>
Hyperplasia histology analysis of the spleen in a transgenic mouse compared to a wild type mouse. Shown is a hematoxylin-eosin coloration of spleen taken from an eight-month-old wild type (A) mouse and an eight-month-old transgenic (B) mouse. Hyperplasia of the folliculi in the transgenic mice can be seen in (B). Both pictures were taken at 100X magnification.
###end p 60
###begin p 61
###xml 226 234 226 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4A</xref>
###xml 260 268 260 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4B</xref>
###xml 287 302 <span type="species:ncbi:10090">transgenic mice</span>
###xml 317 321 <span type="species:ncbi:10090">mice</span>
We did not observe other differences between males and females for relative weight or histology of other organs, compared to non-transgenic animals. Overall, no statistical differences were observed in protein concentrations (Table 4A) or in cell composition (Table 4B) of blood between transgenic mice and wild-type mice. One transgenic female presented lipogenic pigment accumulation in the adrenal gland.
###end p 61
###begin title 62
###xml 59 63 <span type="species:ncbi:10090">mice</span>
Blood chemistry and hematology of transgenic and wild-type mice.
###end title 62
###begin p 63
###xml 117 118 117 118 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 136 137 136 137 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
###xml 167 171 <span type="species:ncbi:10090">mice</span>
Blood was removed from four transgenic and two wild-type mice. Mean measures have been measured for blood chemistry (A) and hematology (B) in transgenic and wild-type mice. Abbreviations in the table: ASAT is aspartate amino transferase; ALAT is alanine amino transferase; CK is creatinine kinase; MCH is mean corpuscular hemoglobin; MCHC is mean corpuscular hemoglobin concentration; MCV is mean corpuscular volume.
###end p 63
###begin title 64
Transgenic-dependent retinal degeneration
###end title 64
###begin p 65
###xml 140 151 140 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI/BIGH3</italic>
###xml 385 393 385 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f5">Figure 5</xref>
###xml 970 978 970 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f6">Figure 6</xref>
###xml 1148 1157 1148 1157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f6">Figure 6B</xref>
###xml 290 305 <span type="species:ncbi:10090">transgenic mice</span>
###xml 379 383 <span type="species:ncbi:10090">mice</span>
###xml 466 470 <span type="species:ncbi:10090">mice</span>
###xml 577 581 <span type="species:ncbi:10090">mice</span>
###xml 688 692 <span type="species:ncbi:10090">mice</span>
###xml 757 761 <span type="species:ncbi:10090">Mice</span>
###xml 895 910 <span type="species:ncbi:10090">transgenic mice</span>
###xml 964 968 <span type="species:ncbi:10090">mice</span>
###xml 1131 1146 <span type="species:ncbi:10090">transgenic mice</span>
Transgenic expression of KE was observed in the retina but not in the cornea of transgenic animals. We therefore investigated the effect of TGFBI/BIGH3 overexpression in retinal tissue. While electroretinogram (ERG) response to increasing intensities flashlights were normal in 2-month-old transgenic mice, we observed a reduction in a- and b-waves in more than 50% of the older mice (Figure 5). In scotopic conditions, at an illumination of 100 mcds/s, 2-month-old mice showed a mean b-wave of 346 mV whereas this mean measure falls to 211 mV at 6 month. Four out six (66.7%) mice showed b-waves even lower than the mean measure. In comparison and in the same conditions, NMRI wild type mice showed no difference in mean values from 2 to 6.5 month of age. Mice with flat ERG also showed a diminution of the retina thickness and a global disorganization of the cell disposition in the retina of transgenic mice expressing the Groenouw mutation compared to control mice (Figure 6). Quantifications of the outer and inner nuclear layers thickness showed a significant diminution of each layer corresponding to a global diminution in transgenic mice (Figure 6B).
###end p 65
###begin p 66
###xml 63 65 63 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A:</bold>
###xml 184 186 184 186 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B:</bold>
###xml 491 492 491 492 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 30 45 <span type="species:ncbi:10090">transgenic mice</span>
###xml 104 119 <span type="species:ncbi:10090">transgenic mice</span>
Electroretinogram analysis of transgenic mice at various ages. A: Amplitudes of b-waves of PGK-Groenouw transgenic mice's electroretinogram (ERG) distributed in function of their age. B: ERG recordings in response to single flashes in scotopic conditions. Two different six-month-old PGK-BIG Groenouw transgenic animals showed either a normal response (upper panel) or a flat ERG (lower panel). Conditions: A1 to V1 shows records with increasing intensities of light from 0.1 to 25000 mcds/m2 and each division of the time axis correspond to 40 ms. U1 to j1 shows records with increasing frequencies of flashlight from 0.5 to 30 Hz and each division of the time axis correspond to 50 ms.
###end p 66
###begin p 67
###xml 87 89 87 89 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A:</bold>
###xml 323 325 323 325 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B:</bold>
###xml 81 85 <span type="species:ncbi:10090">mice</span>
###xml 173 178 <span type="species:ncbi:10090">mouse</span>
###xml 452 456 <span type="species:ncbi:10090">mice</span>
Measurement of the outer nuclear layer of the retina in transgenic and wild-type mice. A: Retinas of a wild type (left panel) and of a PGK-Groenouw transgenic (right panel) mouse stained with hematoxilin-eosin. The bars indicate the outer nuclear layer (ONL) of the retina. The pictures were taken at a 600X magnification. B: ONL and outer plus inner nuclear layer (INL-ONL) of retinas from control nontransgenic (Ctl) and PGK-Groenouw transgenic (Tg) mice at 16 months of age were measured and quantified in the graph.
###end p 67
###begin title 68
Discussion
###end title 68
###begin p 69
###xml 24 35 24 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI/BIGH3</italic>
###xml 270 281 270 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI/BIGH3</italic>
###xml 58 63 <span type="species:ncbi:9606">human</span>
###xml 209 214 <span type="species:ncbi:10090">mouse</span>
###xml 264 269 <span type="species:ncbi:9606">human</span>
Despite many studies on TGFBI/BIGH3 in the development of human corneal dystrophy, its physiologic role is not yet entirely understood. To further elucidate the function of the gene, we generated a transgenic mouse line expressing one of the major mutant forms of human TGFBI/BIGH3.
###end p 69
###begin p 70
###xml 0 11 0 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI/BIGH3</italic>
###xml 298 306 298 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3</xref>
###xml 339 350 339 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI/BIGH3</italic>
###xml 41 46 <span type="species:ncbi:10090">mouse</span>
###xml 333 338 <span type="species:ncbi:9606">human</span>
TGFBI/BIGH3 expression in our transgenic mouse line showed variable transgene amount expressed in different organs. However, our results consistently showed not only a clear overexpression of the protein in the heart and the kidney but a protein expression appeared in the retina and in the brain (Figure 3). Transgene expression of human TGFBI/BIGH3 was also observed in other organs, but to a lesser extent.
###end p 70
###begin p 71
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 485 487 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 501 509 501 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3</xref>
###xml 583 590 583 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 519 534 <span type="species:ncbi:10090">transgenic mice</span>
Usually, viral vectors are known to randomly integrate in the host genome. However, a report by Hacein-Bey-Abina and colleagues [18] challenged this assumption, and the idea of preferred integration sites for viral vectors emerged. The integration sites varied, depending on the type of virus implicated, and occurred within active transcription units and more particularly, within or near genes encoding for proteins with kinase, transferase function, or phosphorylation activity [19,20]. As seen in Figure 3, several transgenic mice shared a same integration site on chromosome 8 (Table 2). We didn't find any gene with retina-specific transcript in this region. The technique used did not allow us to identify all integration sites, and it is likely that other chromosomes regions harbored transgenes. This is corroborated by the results of the Southern blots showing more than two sites of integration.
###end p 71
###begin p 72
###xml 202 213 202 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI/BIGH3</italic>
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 519 526 519 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 673 681 673 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4</xref>
###xml 793 801 793 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3</xref>
###xml 942 950 942 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
###xml 1251 1253 1251 1253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 1459 1460 1459 1460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 90 94 <span type="species:ncbi:10090">mice</span>
###xml 154 159 <span type="species:ncbi:10090">mouse</span>
###xml 502 517 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1600 1605 <span type="species:ncbi:10090">mouse</span>
Transgenic animals did not present apparent macroscopic abnormalities compared to control mice, suggesting that KE overexpression did not severely impair mouse development. Previous studies showed that TGFBI/BIGH3 is involved in cell growth, tumor genesis, wound healing, apoptosis, migration, and osteogenesis among others [21]. This could mean that such actions are under the control of domains not mutated in our experiments. Results of blood analysis suggested that no metabolic change occurred in transgenic mice (Table 4). Moreover, no evident differences were observed at the cellular level except for spleen follicular hyperplasia in the transgenic female animals (Figure 4). We did not obtain any measurable KE expression in the cornea of transgenic animals with the promoter tested (Figure 3). This lack of expression was not due to transcriptional silencing since no transgene insertion was observed in DNA extracted from corneas (Figure 2). A possible explanation could be the systematic elimination of corneal cells overexpressing the transgene. Alternatively, this could be the result of an embryonic selection of corneal cells devoid of transgene, since we previously described that overexpression of KE induce apoptosis in cell lines [22]. It is possible that the KE silencing in the cornea might be consecutive to the method used to generate transgenic animals. Such a selection process may not be present later in life as Bainbridge et al. [7] showed stable transgenic expression in corneal endothelium when the transgene was directly injected in the anterior chamber. A transgenic mouse generated with the traditional method might also generate another expression pattern.
###end p 72
###begin p 73
###xml 125 133 125 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f6">Figure 6</xref>
###xml 183 191 183 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f5">Figure 5</xref>
###xml 755 757 755 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 1128 1135 1128 1135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 1411 1413 1411 1413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 68 83 <span type="species:ncbi:10090">transgenic mice</span>
###xml 245 260 <span type="species:ncbi:10090">transgenic mice</span>
###xml 301 305 <span type="species:ncbi:10090">mice</span>
###xml 377 392 <span type="species:ncbi:10090">transgenic mice</span>
###xml 632 636 <span type="species:ncbi:10090">mice</span>
###xml 782 787 <span type="species:ncbi:10090">mouse</span>
###xml 826 831 <span type="species:ncbi:9606">human</span>
###xml 1319 1334 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1613 1628 <span type="species:ncbi:10090">transgenic mice</span>
Interestingly, we observed an age-dependent retinal degeneration in transgenic mice that was not seen in wild-type controls (Figure 6). The observation was confirmed by ERG analyses (Figure 5). Moreover, lipogenic pigments were also observed in transgenic mice. This pigment is common in normal aging mice, but rare before 18 months of age. The presence of this pigment in our transgenic mice suggests an accelerated aging process that may explain in part the retinal degeneration. The follicular hyperplasia observed in the spleen was found only in female mutants. Again, this finding is relatively common in 6-month-old wild-type mice and increases in frequency with age, which is consistent with an accelerated aging process. A study by Kuro-o et al. [23] described a transgenic mouse line leading to a syndrome resembling human aging. The results showed a short lifespan, infertility, and arteriosclerosis, among others. Interestingly, the authors also noted a slight increase in calcium and phosphorus in blood serum, accompanied with a diminution of leukocytes and lymphocytes. We also observed this tendency in our data (Table 4) but our results are not statistically significant (p=0.59 and 0.65 for difference in calcium and lymphocyte concentrations respectively). This study also noted growth retardation in transgenic mice, which is in accordance with our results. On the other hand, Olsson et al. [24] showed that overexpression of normal proteins can damage photoreceptors because of protein trafficking abnormalities. This observation may be in accordance with the retinal degeneration observed in transgenic mice, but does not explain the early presence of lipogenic pigment and the follicular hyperplasia.
###end p 73
###begin p 74
###xml 86 97 86 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI/BIGH3</italic>
###xml 41 46 <span type="species:ncbi:10090">mouse</span>
###xml 72 77 <span type="species:ncbi:9606">human</span>
###xml 234 238 <span type="species:ncbi:10090">mice</span>
###xml 277 292 <span type="species:ncbi:10090">transgenic mice</span>
###xml 331 335 <span type="species:ncbi:10090">mice</span>
###xml 392 396 <span type="species:ncbi:10090">mice</span>
###xml 520 535 <span type="species:ncbi:10090">transgenic mice</span>
In conclusion, we generated a transgenic mouse line expressing an R555W human mutated TGFBI/BIGH3. Extensive histopathological evaluation, completed by full X-ray and blood analysis showed no evident differences compared to wild-type mice, except for retinal degeneration. The transgenic mice seemed to grow quicker than wild-type mice, as they tended to be bigger than age-matched wild-type mice. The presence of lipogenic pigment, the retinal degeneration, and the follicular hyperplasia of the spleen observed in the transgenic mice suggest an accelerated aging process.
###end p 74
###begin title 75
Acknowledgments
###end title 75
###begin p 76
This work was supported by the Swiss National Science Foundation grant # 3100-066713. We are particularly grateful to Sylvain Crippa, Tatiana Favez, Celine Agosti, and Valerie Buchillier for technical help.
###end p 76
###begin title 77
References
###end title 77
###begin article-title 78
Assignment of granular corneal dystrophy Groenouw type I (CDGG1) to chromosome 5q.
###end article-title 78
###begin article-title 79
Kerato-epithelin mutations in four 5q31-linked corneal dystrophies.
###end article-title 79
###begin article-title 80
BIGH3 mutation spectrum in corneal dystrophies.
###end article-title 80
###begin article-title 81
TGFBI gene mutations in corneal dystrophies.
###end article-title 81
###begin article-title 82
Systemic investigation of keratoepithelin deposits in TGFBI/BIGH3-related corneal dystrophy.
###end article-title 82
###begin article-title 83
###xml 104 109 <span type="species:ncbi:10090">mouse</span>
Activity analysis of housekeeping promoters using self-inactivating lentiviral vector delivery into the mouse retina.
###end article-title 83
###begin article-title 84
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
###xml 48 51 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
In vivo gene transfer to the mouse eye using an HIV-based lentiviral vector; efficient long-term transduction of corneal endothelium and retinal pigment epithelium.
###end article-title 84
###begin article-title 85
###xml 41 44 <span type="species:ncbi:10116">rat</span>
###xml 56 61 <span type="species:ncbi:9606">human</span>
Lentivirus-mediated gene transfer to the rat, ovine and human cornea.
###end article-title 85
###begin article-title 86
###xml 14 19 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 24 28 <span type="species:ncbi:11665?1.0">EIAV</span>
Comparison of HIV-1 and EIAV-based lentiviral vectors in corneal transduction.
###end article-title 86
###begin article-title 87
###xml 65 70 <span type="species:ncbi:9606">human</span>
Cryopreservation and lentiviral-mediated genetic modification of human primary cultured corneal endothelial cells.
###end article-title 87
###begin article-title 88
Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease.
###end article-title 88
###begin article-title 89
Lentiviral transgenesis.
###end article-title 89
###begin article-title 90
Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery.
###end article-title 90
###begin article-title 91
In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector.
###end article-title 91
###begin article-title 92
Polyclonal long-term repopulating stem cell clones in a primate model.
###end article-title 92
###begin article-title 93
Amyloid and non-amyloid forms of 5q31-linked corneal dystrophy resulting from kerato-epithelin mutations at Arg-124 are associated with abnormal turnover of the protein.
###end article-title 93
###begin article-title 94
###xml 51 59 <span type="species:ncbi:9606">patients</span>
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.
###end article-title 94
###begin article-title 95
###xml 27 32 <span type="species:ncbi:9606">human</span>
Retroviral integration and human gene therapy.
###end article-title 95
###begin article-title 96
Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo.
###end article-title 96
###begin article-title 97
Beta ig-h3 mediates osteoblast adhesion and inhibits differentiation.
###end article-title 97
###begin article-title 98
###xml 26 31 <span type="species:ncbi:9606">human</span>
Induction of apoptosis in human corneal and HeLa cells by mutated BIGH3.
###end article-title 98
###begin article-title 99
###xml 16 21 <span type="species:ncbi:10090">mouse</span>
Mutation of the mouse klotho gene leads to a syndrome resembling ageing.
###end article-title 99
###begin article-title 100
###xml 0 15 <span type="species:ncbi:10090">Transgenic mice</span>
###xml 56 61 <span type="species:ncbi:10090">mouse</span>
Transgenic mice with a rhodopsin mutation (Pro23His): a mouse model of autosomal dominant retinitis pigmentosa.
###end article-title 100

